Verax Research Services™ Introduces State-of-the-Art Hemp Research Services Infrastructure - Clients Benefit from $20M Investment and Expertise

Verax Research has secured investment and Intellectual Property licenses to assist Healthcare Product Manufacturer Clients.

ROCKVILLE, Md. (PRWEB) June 05, 2018

Verax Research Services™ Introduces State of the Art Hemp Research Services Infrastructure
Verax Product Development and Manufacturer Clients Benefit from $20M Investment and Expertise

Verax Research Services, Inc. (Verax Research™) introduces the most advanced Hemp Research Services Infrastructure for Verax’s Manufacturer Clients. Verax Research has secured investment and infrastructure Intellectual Property licenses from three companies to assist Verax compile and integrate the most advanced service offering available globally for its Healthcare Product Manufacturer Clients developing hemp-related products.

Verax Research has received the exclusive license for the Cannocopeia™ database of specific Hemp-constituents evidence-based data on the constituents of Hemp from Vitreon America™, Inc. which has the Botanicopeia™ 8,000 plant and 40,000 plant constituent database, first developed by James A. Duke, PhD, founder of Green Farmacy Garden® and Botanica Elaborum™. The Botanicopeia database has twice as many plants and four times the plant constituents registered in the United State Department of Agriculture (“USDA”) database, which Dr. Duke also spearheaded the development for the USDA. From the Botanicopeia database, the Cannocopeia extracted the Hemp-constituents database and Verax Research has created over 100 unique evidence based research reports from this database which can be utilized to advance Verax Research’s Product Development and Manufacturer Clients research.

Verax Research has received a license to the Product Safety Assurance Services Inc. proprietary protocols and systems for testing, validating and certifying pharmaceutical raw materials and finished products for the pharmaceutical manufacturer industry. Verax Research has modified the Product Safety Assurance Services protocols and system for the specific U.S. and other Globally Harmonized Government Agencies requirements to insure the raw material and finished product supply chain security and integrity. Over the last twenty years, 15 of the Top 30 Pharmaceutical Companies have utilized Product Safety Assurance Services for these critical product development and manufacturing requirements to insure the products’ safety for their patients.

To complete the additional transmission and secure transactions auditing of Hemp constituent ingredient purchases from raw materials to finished products, Verax Research licensed Advasur, LLC product raw materials and finished product pedigree and product auditing systems. Verax Research Services now has the most advanced and industry proven infrastructure capabilities to assist its healthcare product development and manufacturing clients develop innovative hemp constituent containing products.

About Verax Research Services, Inc.
Verax Research Services, Inc., founded in June 2017 as a Delaware C-Corporation by proven and trusted Pharmaceutical and Medical Device Executives with a singular objective: Ensure Hemp Research and Product Development Leads to Safe and Effective Healthcare Products. To accomplish this objective, Verax Research provides research, product development and raw material testing, as well as, validation and certification of Hemp constituent raw materials for Verax Research’s pharmaceutical and other healthcare manufacturer clients. Located at Johns Hopkins University, Verax Research has developed the infrastructure to support our clients and to meet their hemp constituent needs. For more information, visit http://www.veraxresearch.com.

Contact:
Carley Welch
Communications Coordinator
c.welch(at)veraxresearch.com
Office: 888-214-2584

For the original version on PRWeb visit: https://www.prweb.com/releases/2018/05/prweb15511614.htm